Herbal Monograph
Cayenne
Capsicum annuum L.
Solanaceae (Nightshade family)
Powerful circulatory catalyst and evidence-based topical analgesic with a 8,000-year history of human use
Overview
Plant Description
Capsicum annuum is an annual or short-lived perennial herbaceous plant (perennial in frost-free climates, typically grown as an annual elsewhere) of the Solanaceae family, growing 30-120 cm (1-4 feet) tall, occasionally reaching 150 cm under favorable conditions. The stems are erect, branching, slightly angular, and become somewhat woody at the base with age. Leaves are alternate, simple, ovate to lanceolate, 4-12 cm long and 2-5 cm wide, with entire margins, glossy dark green upper surface, and a pointed apex. The flowers are solitary or occasionally paired in the leaf axils, small (1-1.5 cm diameter), with 5-7 white to pale greenish-white petals (occasionally with a violet tinge at the base), five stamens with bluish-grey to purple anthers, and a superior ovary. Flowering occurs throughout the growing season. The fruit is a hollow, many-seeded berry (technically a capsule-like berry), extremely variable in shape, size, color, and pungency depending on cultivar -- ranging from small, narrow, tapering pods 5-12 cm long and 1-2 cm wide (classic cayenne type) to large, blocky bell peppers (non-pungent cultivars). Cayenne-type fruits are elongated, conical, often curved, with a smooth, waxy skin that ripens from green through yellow-orange to bright red at maturity. The internal septa and placental tissue (the whitish ribs to which seeds are attached) contain the highest concentration of capsaicinoids. Seeds are numerous, flat, kidney-shaped, pale yellow, 3-5 mm in diameter. The entire plant has a characteristic pungent aroma, especially when the fruits or leaves are crushed.
Habitat
Capsicum annuum is a tropical to warm-temperate species native to the Americas, believed to have been domesticated in central-eastern Mexico approximately 6,000-8,000 years ago from wild progenitor populations. Wild-type Capsicum annuum var. glabriusculum (Chiltepin or Bird Pepper) still grows as a perennial shrub in southern North America, Mexico, Central America, and northern South America, typically in semi-arid to subtropical habitats including thorn scrub, dry forests, canyon bottoms, and disturbed areas, often in the partial shade of nurse trees. Cultivated cayenne thrives in well-drained, fertile, slightly acidic to neutral soils (pH 6.0-7.0) with full sun exposure, moderate humidity, and warm temperatures (optimal 21-29 degrees C / 70-85 degrees F). It is frost-sensitive and requires a long growing season (60-90 days to fruit maturity from transplanting).
Distribution
Now cultivated pantropically and in warm temperate regions worldwide, Capsicum annuum is one of the most widely grown spice crops on Earth. Major producing countries include China (by far the largest producer), India, Mexico, Indonesia, Turkey, Spain, Nigeria, Ethiopia, Thailand, and the United States. China and India together account for approximately 65-70% of global production. The plant has been distributed globally since the Colombian Exchange beginning in the late 15th century, spreading from Mesoamerican origin to become integral to the cuisines and folk medicines of virtually every tropical and subtropical culture within 200 years of European contact. Cayenne-type cultivars (long, thin, highly pungent red peppers) are particularly associated with the Cayenne region of French Guiana (origin of the common name), Louisiana Creole cuisine, West African cooking, and South and Southeast Asian traditions.
Parts Used
Dried ripe fruit (Capsici fructus)
Preferred: Finely ground dried powder (cayenne pepper); standardized capsules; tincture
The dried ripe fruit is the official pharmacopeial drug in all major herbal pharmacopeias including Commission E, WHO, EMA, BHP, and the European Pharmacopoeia. The whole dried fruit is ground to produce cayenne powder, the most common internal preparation. Capsaicinoid content is concentrated in the placental tissue and septa (internal ribs) rather than the flesh or seeds, though the entire fruit is used medicinally. Pungency (and thus capsaicinoid content) varies by cultivar, growing conditions, and processing -- standard medicinal cayenne powder is typically 30,000-90,000 SHU. The dried fruit contains the full complement of capsaicinoids, carotenoids, flavonoids, vitamins, and other constituents.
Oleoresin of Capsicum (Capsici oleoresina)
Preferred: Standardized oleoresin for compounding into creams, plasters, and patches; pharmaceutical-grade preparations
A concentrated semi-solid extract obtained by percolation of dried, ground capsicum fruits with a suitable organic solvent (typically ethanol, ethyl acetate, or acetone), followed by solvent evaporation. The oleoresin concentrates the capsaicinoids, carotenoid pigments, and fixed oils while removing much of the fibrous plant material. Oleoresin of capsicum is the standardized starting material for most pharmaceutical topical preparations (creams, patches, plasters) and is used in the food industry for consistent heat levels. Capsaicinoid content of commercial oleoresin ranges from 5-15% total capsaicinoids, standardized by HPLC.
Fresh fruit
Preferred: Fresh fruit for culinary use, fresh-plant tincture, or fresh poultice
Fresh cayenne peppers are used culinarily and in some traditional medicine preparations (fresh juice, poultices, fresh-plant tincture). The fresh fruit contains higher vitamin C content than the dried form (cayenne is among the richest food sources of vitamin C at 100-240 mg per 100 g fresh weight, though much is lost during drying). Fresh fruit can be used to prepare a fresh-plant tincture (1:2 in 95% ethanol) that some herbalists prefer for acute circulatory stimulation. Fresh peppers are also used in traditional poultice preparations in Caribbean and Latin American folk medicine.
Key Constituents
Capsaicinoids (vanillylamides of branched-chain fatty acids)
Capsaicinoids are the primary bioactive and pharmacologically distinctive constituents of cayenne, responsible for virtually all of its major therapeutic actions: topical analgesia (via TRPV1 activation and subsequent substance P depletion from sensory nerve terminals), circulatory stimulation, thermogenesis, counterirritant/rubefacient effects, and the characteristic pungent taste that drives digestive sialagogue and carminative actions. The TRPV1-mediated analgesic mechanism is one of the best-characterized mechanisms of action in phytotherapy and has led to FDA-approved topical analgesic products. Capsaicinoid content (measured by HPLC and expressed as Scoville Heat Units or percent capsaicinoids) is the primary quality and potency marker for cayenne products. The relationship is: 1 ppm capsaicin = approximately 15 SHU; therefore, 1% capsaicin = approximately 150,000 SHU.
Carotenoid pigments
The carotenoid pigments contribute significant antioxidant activity and are responsible for the intense red color that serves as a visual quality indicator for cayenne products (pale or orange-brown powder indicates degradation or adulteration). Beta-carotene provides provitamin A activity. The carotenoid content supports cayenne's traditional use as a nutritive tonic and contributes to its role as a whole-food source of antioxidants. Capsanthin and capsorubin have demonstrated anti-inflammatory and antioxidant effects in cell culture studies. Carotenoid degradation is a primary marker of cayenne powder deterioration -- color fading indicates oxidative loss of both pigments and likely capsaicinoids.
Vitamins
The vitamin content of cayenne, particularly the exceptionally high vitamin C in fresh fruits and the provitamin A carotenoids retained in dried preparations, contributes to its historical and traditional use as a nutritive tonic, antiscorbutic, and immune-supportive herb. The vitamin C content is particularly notable in historical context: cayenne was used empirically to prevent and treat scurvy-like conditions in tropical seafaring and exploration long before the identification of ascorbic acid. In contemporary herbal practice, the vitamin content is a supporting benefit rather than a primary therapeutic driver.
Steroidal saponins
The steroidal saponins contribute modestly to cayenne's antimicrobial properties but are not considered primary active constituents in fruit-based preparations. They are more relevant to the pharmacology of whole-plant preparations or root extracts used in some traditional systems.
Flavonoids
Flavonoids contribute to the overall antioxidant and anti-inflammatory activity of cayenne and may synergize with capsaicinoids and carotenoids. The capillary-strengthening (vasoprotective) action of flavonoids is complementary to cayenne's circulatory stimulant effects.
Volatile oil
The volatile oil contributes primarily to the aromatic and carminative properties of cayenne and plays a secondary role in the overall therapeutic profile. The aromatic compounds enhance the sialagogue reflex and contribute to the sensory experience that stimulates digestive secretions.
Fixed oil (seed oil)
The fixed oil is a minor constituent of therapeutic relevance in whole-fruit preparations but contributes to the lipid-soluble compound matrix. Linoleic acid is an essential fatty acid. The seed oil may enhance absorption of lipophilic capsaicinoids and carotenoids when cayenne is consumed as a whole-fruit preparation.
Herbal Actions
The most historically significant and widely recognized action of cayenne in Western herbal medicine. Cayenne powerfully stimulates peripheral blood circulation, increasing blood flow to the extremities and mucous membranes. This action is mediated by capsaicin activation of TRPV1 receptors on sensory neurons, triggering release of calcitonin gene-related peptide (CGRP) and substance P, which cause local vasodilation and increased tissue perfusion. Systemically, capsaicin promotes vasodilation through both neurogenic and endothelium-dependent mechanisms (nitric oxide release). In Thomsonian herbal medicine (Samuel Thomson, early 19th century America), cayenne was designated the 'Number 2' remedy -- second only to lobelia in importance -- and was the archetypal 'catalyst herb,' believed to carry other herbs deeper into the tissues and enhance their absorption and activity. This 'catalyst' concept has partial modern validation: capsaicin has been shown to enhance the bioavailability of certain co-administered compounds, possibly through increased gastrointestinal blood flow, enhanced mucosal permeability, and/or inhibition of intestinal P-glycoprotein efflux transporters. Modern herbalists continue to use small amounts of cayenne in herbal formulas as a 'driver' or 'activator' to improve overall formula efficacy.
[1, 5, 6, 8]Applied topically, cayenne produces marked local hyperemia (redness, warmth, and increased blood flow) through TRPV1 activation on cutaneous sensory neurons. This rubefacient effect is followed by a counterirritant analgesic phase as continued TRPV1 stimulation leads to sensory nerve desensitization and substance P depletion. The Commission E monograph approves Capsici fructus for external use as a counterirritant for painful muscle spasm in the shoulder, arm, and spine. The EMA community herbal monograph recognizes topical capsicum preparations for relief of muscle pain. The rubefacient action distinguishes cayenne from other topical analgesics: it acts through a specific receptor-mediated mechanism (TRPV1) rather than non-specific irritation.
[1, 2, 3, 4]Topical capsaicin is one of the most well-established and mechanistically understood analgesic actions in phytotherapy. The analgesic mechanism proceeds through a well-defined sequence: (1) Capsaicin binds to TRPV1 on C-fiber nociceptive terminals, causing an initial burning sensation and release of neuropeptides (substance P, CGRP); (2) With repeated application (typically over 3-7 days), TRPV1 receptors undergo desensitization through receptor downregulation and calcium-mediated defunctionalization; (3) Substance P stores in the nerve terminals become depleted, reducing pain signal transmission to the spinal cord (substance P is the primary neurotransmitter for pain signaling in C-fibers); (4) Prolonged high-concentration exposure can cause reversible 'defunctionalization' of nociceptive fibers, effectively silencing pain transmission without nerve damage. This mechanism has been validated by multiple Cochrane reviews (Mason et al. 2004, Derry et al. 2017) and has led to FDA-approved topical capsaicin products for neuropathic pain at both OTC (0.025-0.1%) and prescription (8% patch, Qutenza) concentrations.
[9, 10, 11, 17]Relieves intestinal gas and bloating
Cayenne promotes the expulsion of gas from the gastrointestinal tract and relieves bloating and flatulence. This carminative action is mediated by stimulation of digestive secretions (gastric acid, bile, pancreatic enzymes), increased gastrointestinal motility via activation of TRPV1 receptors on enteric neurons, and enhanced mucosal blood flow. Contrary to the common misconception that spicy foods cause ulcers, capsaicin in moderate doses has been shown to be gastroprotective: it stimulates mucus and bicarbonate secretion from gastric mucosa, increases gastric mucosal blood flow (which protects against ischemic damage), and inhibits acid secretion at higher doses. The Commission E monograph lists dyspeptic complaints among the internal indications for capsicum.
[1, 2, 5]Promotes perspiration
Cayenne promotes perspiration, particularly when taken internally as hot preparations (tea, powder in warm water). The diaphoretic action is mediated by capsaicin activation of TRPV1 thermoreceptors in the hypothalamus and peripheral tissues, triggering thermoregulatory sweating. This is the pharmacological basis of the common experience of sweating while eating spicy food. In traditional herbal medicine, cayenne combined with other diaphoretic herbs (elderflower, yarrow, peppermint) is a classic combination for the acute management of febrile conditions, promoting perspiration to 'break a fever.' Samuel Thomson specifically valued cayenne as a warming diaphoretic to restore internal heat and promote therapeutic sweating.
[4, 5, 8]Cayenne powerfully stimulates salivary secretion upon contact with the oral mucosa, through direct activation of TRPV1 receptors on the tongue and palate and reflexive stimulation of salivary glands. Increased salivation initiates the digestive cascade: the reflex arc extends to stimulate gastric, pancreatic, and biliary secretions. This sialagogue action is the beginning of cayenne's broader stimulation of the entire digestive process and is one of the most immediately noticeable physiological effects of taking cayenne internally.
[5, 6]Cayenne has a paradoxical traditional reputation as both a circulatory stimulant and a styptic (agent that stops bleeding). Applied topically to minor cuts and wounds, cayenne powder is reported in Thomsonian and eclectic medical traditions to promote rapid hemostasis. The proposed mechanism involves local vasospasm in small vessels caused by initial high-concentration capsaicin exposure, combined with promotion of platelet aggregation at the wound site. Internally, cayenne has been traditionally claimed to 'equalize blood pressure' and stop internal hemorrhage, though this claim lacks rigorous clinical validation. The styptic action is primarily documented in traditional/empirical sources (Thomson, eclectic physicians) rather than modern clinical trials.
[5, 8]Kills or inhibits the growth of microorganisms
Capsaicin and capsaicinoid fractions demonstrate antimicrobial activity against various gram-positive and gram-negative bacteria, as well as some fungi, in vitro. The antimicrobial mechanism involves disruption of bacterial cell membrane integrity. Capsicidins (steroidal saponins) also contribute antifungal activity. While antimicrobial potency is modest compared to pharmaceutical antibiotics, the action contributes to cayenne's traditional use in food preservation (long pre-dating refrigeration in tropical climates) and may contribute to therapeutic effects in sore throat (gargle) and wound management preparations.
[2, 6]Capsaicin increases energy expenditure and fat oxidation through activation of TRPV1 receptors and sympathetic nervous system stimulation, promoting catecholamine release (norepinephrine) from adrenal medulla and sympathetic nerve terminals. The thermogenic effect is measurable but modest: clinical studies report increases in metabolic rate of approximately 5-20% for 1-2 hours post-ingestion. This action is the basis for cayenne's inclusion in many commercial 'fat-burning' or 'metabolism-boosting' supplements, though the magnitude of the effect is insufficient for clinically meaningful weight loss as a standalone intervention.
[6, 16]Therapeutic Indications
Musculoskeletal System
Neuropathic pain (post-herpetic neuralgia, diabetic peripheral neuropathy)
Topical capsaicin is one of the best-validated phytotherapeutic interventions for neuropathic pain. The Cochrane review by Derry et al. (2017) evaluated high-concentration (8%) capsaicin patches for neuropathic pain and found that a single 30-60 minute application of the 8% patch (Qutenza) provided significant pain relief lasting 8-12 weeks. For post-herpetic neuralgia specifically, the number needed to treat (NNT) was approximately 8.8 for 30% pain reduction. The FDA has approved topical capsaicin products for neuropathic pain: OTC low-concentration creams (0.025-0.1%) for general pain relief and the prescription 8% capsaicin patch (Qutenza, approved 2009) for post-herpetic neuralgia and diabetic peripheral neuropathy of the feet. The analgesic mechanism (TRPV1 desensitization and substance P depletion) is among the most thoroughly characterized in pain pharmacology. Mason et al. (2004) Cochrane review of low-concentration topical capsaicin found it more effective than placebo for both neuropathic pain and musculoskeletal pain conditions.
[3, 9, 10, 17]Osteoarthritis pain (topical)
Deal et al. (1991) conducted a double-blind, placebo-controlled RCT of topical capsaicin (0.025%) cream applied four times daily for 4 weeks in osteoarthritis patients. Capsaicin-treated patients had significantly greater reduction in pain (visual analog scale) compared to placebo-treated controls (P < 0.01). The Mason et al. (2004) Cochrane review included OA studies and found a relative benefit of 1.4 (95% CI 1.2-1.7) for capsaicin over placebo. The American College of Rheumatology conditionally recommends topical capsaicin for hand and knee OA in their clinical practice guidelines. The analgesic effect requires regular application (3-4 times daily) for at least 1-2 weeks to achieve maximal benefit, reflecting the time required for substance P depletion.
[1, 9, 11]Muscle pain and spasm (topical counterirritant)
The Commission E monograph specifically approves topical capsicum preparations (plasters, semi-solid preparations) for 'painful muscle spasm in the area of the shoulder, arm, and spine.' The EMA community herbal monograph (2012) recognizes 'well-established use' of capsicum-containing plasters for muscle pain based on long clinical tradition. The counterirritant/rubefacient mechanism (TRPV1-mediated local hyperemia and subsequent analgesia) provides both immediate warming relief and longer-term pain reduction through substance P depletion. Commercial capsicum plasters (e.g., ABC Warme-Pflaster in Germany) have been in continuous clinical use for over a century.
[1, 3, 4]Rheumatoid arthritis pain (topical, adjunctive)
Limited clinical data specifically in rheumatoid arthritis, though the same TRPV1/substance P mechanism applies. McCarthy and McCarthy (1992) reported significant pain reduction with topical capsaicin in RA patients. The counterirritant and analgesic mechanism is non-disease-specific and should theoretically benefit pain of any joint origin. Used as a topical adjunct to systemic disease-modifying therapy.
[3, 9]Cluster headache (intranasal capsaicin)
Fusco et al. (1994) and Marks et al. (1993) investigated intranasal capsaicin application for cluster headache prophylaxis. Repeated application of capsaicin (as civamide/zucapsaicin) to the nasal mucosa ipsilateral to the headache produced significant reduction in headache frequency and severity. The mechanism involves desensitization of trigeminal nerve C-fibers and depletion of substance P and CGRP from trigeminal nerve terminals that innervate the nasal mucosa and meningeal blood vessels. The approach is investigational and not yet established in standard clinical practice, but represents a novel application of TRPV1-mediated analgesia.
[14, 15]Cardiovascular System
Poor peripheral circulation (cold extremities, chilblains)
One of the most time-honored indications for cayenne across multiple traditional systems. Cayenne is a powerful peripheral vasodilator, increasing blood flow to the extremities (hands, feet, and skin surface). In Thomsonian medicine, cayenne was considered essential for 'restoring the internal heat' and overcoming cold, stagnant circulatory conditions. Hoffmann (2003) lists poor peripheral circulation as a primary indication. The mechanism involves TRPV1-mediated release of CGRP, a potent vasodilator, from perivascular sensory nerve terminals. Clinical validation is largely traditional and empirical, with limited modern RCT data for this specific indication, though the pharmacological mechanism is well-characterized.
[4, 5, 6, 8]Raynaud's phenomenon
Cayenne is traditionally recommended by Western herbalists for Raynaud's disease and phenomenon (episodic vasospasm of digital arteries causing white, then blue, then red discoloration of fingers and toes in response to cold or emotional stress). The rationale is cayenne's peripheral vasodilating and warming action. Both internal use (capsules, tincture) and external use (hand/foot soaks with cayenne, cayenne-containing creams/salves) are employed. Clinical evidence is limited to traditional use, case reports, and empirical clinical experience; no large-scale RCTs have been conducted for this specific indication.
[5, 6]Cardiovascular tonic (general circulatory support)
In the Thomsonian and eclectic medical traditions, cayenne was considered one of the most important cardiovascular herbs, used to 'equalize the circulation' and support overall cardiovascular function. Samuel Thomson wrote that cayenne was 'the most powerful stimulant known; its power is entirely congenial to nature, being perfectly harmless.' Modern evidence supports some cardiovascular-relevant mechanisms: capsaicin promotes nitric oxide release from endothelial cells, inhibits platelet aggregation, may modestly reduce blood pressure via CGRP-mediated vasodilation, and promotes favorable effects on lipid metabolism in some studies. However, large-scale cardiovascular outcome data are lacking.
[5, 8]Digestive System
Dyspepsia (functional, with atonic digestion)
The Commission E monograph approves capsicum internally for dyspeptic complaints. Cayenne stimulates the entire digestive process: salivation, gastric acid secretion, pepsin production, bile flow, and pancreatic enzyme release. This broad secretory stimulation makes cayenne particularly indicated for atonic dyspepsia (weak, sluggish digestion with bloating, gas, and a sensation of food sitting heavily in the stomach). The WHO monograph similarly recognizes the use of capsicum for digestive disorders. Importantly, capsaicin at moderate doses is gastroprotective rather than gastro-irritant: it stimulates gastric mucus and bicarbonate secretion and enhances mucosal blood flow. The common belief that spicy food causes stomach ulcers has been contradicted by epidemiological and pharmacological evidence -- populations with high chili consumption do not have elevated rates of gastric ulcer disease.
[1, 2, 5]Appetite stimulation (anorexia, poor appetite)
Cayenne is a traditional appetite stimulant in multiple systems. The sialagogue, bitter-pungent taste, and reflex stimulation of gastric secretions promote appetite through both sensory and physiological pathways. In Thomsonian medicine, cayenne was routinely included in preparations for patients with poor appetite and debility. In Ayurveda, pungent spices including Capsicum are used to 'kindle agni' (digestive fire) in conditions of low appetite and sluggish metabolism.
[4, 5]Flatulence and bloating (carminative indication)
Cayenne's carminative action helps expel intestinal gas and relieve abdominal bloating. The mechanism involves stimulation of gastrointestinal motility via TRPV1 activation on enteric neurons, promotion of digestive secretions that improve food breakdown, and direct smooth muscle effects. Listed in the BHP and traditional herbal references as a carminative for flatulent dyspepsia.
[4, 5]dermatological
Psoriasis (topical capsaicin)
Bernstein et al. (1986) conducted a landmark double-blind, vehicle-controlled study of topical capsaicin (0.025%) in psoriasis patients. Capsaicin-treated patients showed significant reduction in scaling, erythema, and pruritus compared to vehicle control. The mechanism involves depletion of substance P from cutaneous nerve terminals, which reduces the neurogenic inflammatory component that contributes to psoriatic plaque formation and pruritus. Substance P has been found at elevated levels in psoriatic skin. Subsequent studies have confirmed the efficacy of topical capsaicin for psoriasis symptoms, and the indication is recognized in clinical dermatology guidelines as an adjunctive topical therapy.
[9, 12]Pruritus (itch, various causes)
Topical capsaicin is effective for various pruritic conditions through substance P depletion and sensory nerve desensitization. Studies have demonstrated benefit in pruritus associated with psoriasis, hemodialysis-related pruritus, notalgia paresthetica, brachioradial pruritus, and other chronic itch conditions. The application must be repeated consistently (3-4 times daily for several weeks) to achieve and maintain substance P depletion. Initial application causes transient intensification of itch/burning that diminishes with continued use.
[10, 12]Respiratory System
Common cold and influenza (diaphoretic/warming remedy)
Cayenne is a cornerstone herb in traditional Western herbal management of acute upper respiratory infections, particularly when the presentation involves chills, cold extremities, pale complexion, and thin, watery nasal discharge (cold/damp presentation). Used as a hot infusion or added to other diaphoretic teas (elderflower, yarrow, peppermint) to promote therapeutic sweating and 'break a fever.' The warming, circulatory-stimulating action is believed to enhance immune cell delivery to infected tissues. In the Thomsonian system, cayenne was the primary warming stimulant used in the 'course of medicine' (a systematic treatment protocol involving emesis, sweating, and restoration). While specific RCT data on cayenne for URI outcomes are lacking, the traditional use is extensive and the underlying pharmacological mechanisms (peripheral vasodilation, diaphoresis, immune stimulation) are established.
[4, 5, 8]Sore throat (gargle)
A dilute cayenne gargle is a traditional remedy for sore throat, tonsilitis, and pharyngitis. The mechanism involves counterirritant analgesia (temporary burning followed by pain relief via TRPV1 desensitization), increased local blood flow delivering immune cells, and mild antimicrobial activity. Typically prepared by adding 1/4 to 1/2 teaspoon cayenne powder to a cup of warm water with honey and gargling (not swallowing in large amounts). The treatment is uncomfortable initially but many patients report significant pain relief within minutes.
[5]metabolic
Thermogenesis and metabolic rate enhancement
Multiple clinical studies have demonstrated that capsaicin ingestion acutely increases energy expenditure (diet-induced thermogenesis) and fat oxidation. Whiting et al. (2012) conducted a meta-analysis of studies evaluating capsaicin/capsinoids on energy expenditure and found a statistically significant increase in metabolic rate following capsaicin consumption. The thermogenic effect is mediated by TRPV1 activation, sympathetic nervous system stimulation, and increased catecholamine release. However, the effect size is modest (approximately 50-100 additional calories expended per day at culinary doses), and clinical significance for weight management as a standalone intervention is limited. Capsaicin may have a more meaningful role as part of a comprehensive approach to metabolic health support.
[6, 16]Nervous System
Diabetic peripheral neuropathy pain (topical)
Topical capsaicin for diabetic peripheral neuropathy pain is FDA-approved (8% capsaicin patch, Qutenza) and supported by multiple RCTs and systematic reviews. The Capsaicin Study Group (1991) demonstrated significant pain reduction with 0.075% capsaicin cream in diabetic neuropathy. The 8% patch provides sustained pain relief for 8-12 weeks after a single 30-minute application. This indication represents one of the most thoroughly validated topical analgesic applications in phytotherapy-derived medicine.
[9, 10, 13]Immune System
Immune support (traditional warming stimulant)
In traditional systems, cayenne is valued as a warming stimulant that 'raises the vital force' and supports the body's defense against acute infection. The Thomsonian system placed enormous emphasis on maintaining internal warmth as the foundation of health, with cayenne as the primary tool. Modern evidence shows that capsaicin modulates immune cell function: at low concentrations it can enhance macrophage phagocytosis and NK cell activity, while at high concentrations it may suppress certain inflammatory pathways. The circulatory-stimulating action enhances delivery of immune cells to sites of infection. Cayenne is not classified as an immunomodulator in the same sense as echinacea or reishi, but its role as a warming circulatory stimulant supports immune function indirectly.
[5, 8]Energetics
Temperature
hot
Moisture
dry
Taste
Tissue States
cold/depression, damp/stagnation, damp/relaxation
Cayenne is among the hottest and most pungent herbs in the Western materia medica, classified as hot in the third or fourth degree in the traditional Galenic system. Its energetic profile is intensely warming and drying, making it a specific remedy for cold, damp, and stagnant tissue states: poor peripheral circulation, cold extremities, sluggish digestion with bloating and gas, pale and boggy mucous membranes, and general metabolic depression. In TCM, La Jiao (Capsicum) is classified as hot in nature, pungent in taste, entering the Spleen, Stomach, and Heart meridians, used to warm the middle jiao, dispel cold, and invigorate Blood. In Ayurveda, Marich (peppers including Capsicum) is classified as hot (ushna), pungent (katu), and light (laghu), increasing Pitta and Agni (digestive fire) while reducing Kapha and Vata. The pungent taste in Ayurvedic pharmacology is associated with fire and air elements. Cayenne is CONTRAINDICATED in hot, dry, and inflamed tissue states: acute gastritis, acid reflux, hot flashes, bleeding hemorrhoids, or any condition with excessive heat and dryness. Constitutional types who are already hot and dry (Pitta-dominant in Ayurveda, choleric in Galenic medicine) should use cayenne sparingly. CAVEAT: Herbal energetics are interpretive frameworks within traditional medicine systems, not standardized across all practitioners.
Traditional Uses
Thomsonian medicine (Samuel Thomson, early 19th-century America)
- Designated as 'Number 2' in Thomson's numbered remedy system -- the second most important medicine after Lobelia (Number 1)
- Primary warming stimulant used to 'raise the internal heat' in nearly all disease conditions
- Central to the 'course of medicine' treatment protocol: cayenne tea given throughout the process of emesis, steaming, and recovery
- Combined with lobelia for emetic/stimulant treatments (cayenne prevented collapse and maintained warmth during lobelia-induced emesis)
- Used for all cold/damp disease presentations: poor circulation, debility, weak digestion, pallor, cold extremities
- Applied topically as a poultice for muscular pain, rheumatism, and sprains
- Given internally for febrile conditions to promote sweating and 'equalize the circulation'
- Used as a styptic for internal and external hemorrhage
- Combined with composition powder (a blend of bayberry, ginger, cloves, cayenne, and pine bark) as a general restorative
"Samuel Thomson (1769-1843) wrote in New Guide to Health; or, Botanic Family Physician (1822): 'There is no article, in my whole practice, that I make so much use of as Cayenne [...] It is so perfectly congenial to the system that it never produces any bad effects [...] it raises and distributes the internal heat, restores the digestive powers, and produces a strong perspiration.' Thomson classified cayenne as 'the most powerful stimulant that has ever been discovered' and used it in virtually every clinical encounter. The Thomsonian movement, which at its peak in the 1830s-1840s had an estimated 3-4 million adherents in the United States, placed cayenne at the center of its therapeutic philosophy: disease was fundamentally a loss of vital heat, and cayenne was the supreme agent for its restoration."
Eclectic medicine (19th-century American, post-Thomsonian)
- Circulatory stimulant for cold extremities and peripheral vascular insufficiency
- Internal hemorrhage (hemoptysis, menorrhagia, hematuria) -- believed to 'equalize blood pressure'
- Atonic dyspepsia and flatulence
- Low-grade fevers with debility (combined with quinine)
- Delirium tremens and alcoholic debility
- Sore throat gargle (dilute cayenne infusion with honey)
- As an adjuvant to enhance the action of other medicinal agents
"John King's American Dispensatory (1854, revised editions through 1898) describes Capsicum as 'a powerful and permanent stimulant, producing a sense of heat in the stomach, and a general glow over the body, without narcotic effect. It is much used as a condiment, and in medicine is employed to rouse the system from a state of collapse, or when the vital powers are low.' The Eclectics refined the Thomsonian use of cayenne, applying it with greater specificity and combining it within sophisticated multi-herb formulas."
[5]
Traditional Chinese Medicine (TCM)
- La Jiao (辣椒): classified as acrid/pungent and hot, entering the Spleen and Stomach meridians
- Warming the middle jiao to treat cold-type stomachache, poor appetite, and vomiting
- Dispelling cold and dampness to treat diarrhea and dysentery from cold accumulation
- Invigorating blood circulation to treat cold bi syndrome (cold-type arthralgia and numbness)
- External application for rheumatic pain, frostbite, and lumbar pain
- Not a classical herb in the Chinese Pharmacopoeia but widely used in folk medicine, especially in Sichuan, Hunan, and Guizhou provinces
"Capsicum arrived in China via Portuguese and Spanish traders in the late 16th century (post-Columbian Exchange) and was rapidly incorporated into both cuisine and folk medicine, particularly in the provinces known for spicy food. In TCM folk classification, La Jiao is used to warm the Spleen and Stomach, dispel internal cold, and promote qi and blood circulation. It is not traditionally categorized in the classic Chinese Pharmacopoeia as a primary medicinal herb but is widely used in regional folk medicine traditions and is recognized in modern Chinese herbal reference works."
Ayurvedic medicine
- Known as Marich or Lanka Maricha; classified as katu (pungent), ushna virya (hot potency), katu vipaka (pungent post-digestive effect)
- Kindling agni (digestive fire) in conditions of mandagni (low digestive fire) with ama (metabolic toxins)
- Reducing Kapha dosha: treats cold, congestion, heaviness, and sluggish metabolism
- Treating cold-type respiratory conditions: rhinitis, sinusitis, bronchitis with white phlegm
- Stimulating rakta dhatu (blood tissue) circulation and treating cold-type vascular conditions
- External application in taila (medicated oil) for joint pain and muscle stiffness
- Contraindicated in Pitta-dominant conditions: gastritis, peptic ulcer, inflammatory conditions, hot flashes
"While Capsicum is a New World plant not present in the earliest Ayurvedic texts (which predate the Columbian Exchange), it was quickly adopted into Ayurvedic practice after its introduction to India by Portuguese traders in the 16th century. It is classified within the same pharmacological category as black pepper (Piper nigrum, Maricha) and long pepper (Piper longum, Pippali) as a hot, pungent digestive and circulatory stimulant. Capsicum is particularly valued in Ayurveda for its ability to strongly increase agni without the potential for long-term tissue depletion associated with chronic use of the most heating spices."
[6]
Mesoamerican and Native American traditional medicine
- Archaeological evidence of Capsicum use in the Americas dates to approximately 7500-6000 BCE (earliest known cultivation in Mesoamerica)
- Maya and Aztec civilizations used chili peppers as both food and medicine, including for toothache, gastrointestinal disorders, and as a ritual fumigant
- Applied as a topical remedy for muscle and joint pain (poultice)
- Used to treat digestive disorders, parasitic infections, and respiratory congestion
- Mixed with cacao in ritual and medicinal beverages (Aztec 'chocolatl')
- Used as a fumigant and disciplinary tool: children were punished by exposure to chili smoke
- Chili smoke inhalation used in some traditions for ritual purification and to treat headache and congestion
"Capsicum peppers have the longest continuous history of human use of any cultivated spice plant, with archaeological evidence from caves in the Tehuacan Valley (Mexico) dating to approximately 7000-5500 BCE. The Florentine Codex (compiled by Fray Bernardino de Sahagun, 1575-1577) documents extensive Aztec medicinal use of chili peppers: treatments for toothache (chili applied directly), cough and chest congestion (chili-infused steam inhalation), and sore throat (chili gargle). Pre-Columbian Capsicum cultivation and use extended from Mesoamerica through the Caribbean and into South America, with each culture developing distinct cultivars and medicinal applications."
[2]
Caribbean and Latin American folk medicine
- Hot pepper tea for fevers, colds, and flu (warming diaphoretic)
- External pepper-and-rum liniment for rheumatic and muscle pain
- Cayenne-honey-lemon preparations for sore throat and respiratory congestion
- Digestive tonic for poor appetite and sluggish digestion
- Fresh hot pepper juice applied to toothache (counterirritant analgesic)
- Used as a vermifuge (antihelminthic) in some Caribbean island traditions
"Cayenne pepper features prominently in the folk medicine traditions of the Caribbean and Latin America, where the plant has been cultivated continuously since pre-Columbian times. The common name 'cayenne' derives from the French Guianese city of Cayenne, reflecting the Caribbean/South American association. In Caribbean bush medicine, pepper tea (hot pepper infused in boiling water) is a standard home remedy for colds, fevers, and digestive complaints. Topical applications of pepper-infused rum or oil are used for joint and muscle pain throughout the region."
[5]
European herbal medicine (post-16th century)
- Introduced to European medicine via Spanish and Portuguese colonial trade routes in the late 15th-16th century
- Adopted rapidly as a warming stimulant and circulatory tonic
- Used in plaster/poultice form for rheumatic pain and lumbago (capsicum plasters remain in continuous use in European pharmacy)
- Internal use for poor digestion, flatulence, and atonic bowel conditions
- Gargle for sore throat and tonsillitis
- Included in many compound warming liniments and embrocations
"Capsicum entered European herbal practice within decades of Columbus's first voyage (1492). Nicholas Monardes, a Spanish physician, described medicinal uses of capsicum in his Historia Medicinal (1574). Gerard's Herball (1597) noted that capsicum was already widely cultivated in England. By the 18th century, capsicum was official in the London Pharmacopoeia. The capsicum plaster became one of the most enduring OTC pharmaceutical products in European pharmacy, remaining in continuous commercial production from the 19th century to the present day."
Modern Research
Cochrane review: low-concentration topical capsaicin for chronic pain
Systematic review and meta-analysis of randomized controlled trials evaluating low-concentration (0.025-0.075%) topical capsaicin for chronic musculoskeletal and neuropathic pain conditions. This was the first comprehensive Cochrane assessment of topical capsaicin analgesic efficacy.
Findings: Six double-blind, placebo-controlled trials in musculoskeletal pain (n=656) and four in neuropathic pain (n=389) met inclusion criteria. For musculoskeletal pain, topical capsaicin was significantly more effective than placebo: relative benefit 1.4 (95% CI 1.2-1.7) and NNT of 8.1 (95% CI 4.6-34) for 50% pain relief. For neuropathic pain, relative benefit was 1.4 (95% CI 1.1-1.8) with NNT of 5.7 (95% CI 4.0-10.0). Local side effects (burning, stinging, erythema) were common but led to withdrawal in only a small proportion of subjects. The review concluded that topical capsaicin has moderate efficacy for chronic pain and may be a useful adjunct, particularly for patients unable to tolerate systemic analgesics.
Limitations: Studies generally small (30-200 participants each). Blinding is inherently difficult with capsaicin due to the obvious burning sensation, potentially allowing unblinding. Heterogeneous pain conditions grouped together. Application four times daily is a significant compliance burden. Follow-up periods generally short (4-8 weeks).
[9]
Cochrane review: high-concentration topical capsaicin for neuropathic pain
Updated Cochrane systematic review of high-concentration (8%) capsaicin patch (Qutenza) for neuropathic pain, including post-herpetic neuralgia, HIV-associated neuropathy, and diabetic peripheral neuropathy.
Findings: Eight studies with 2488 participants were included in the analysis. A single 30-60 minute application of the 8% capsaicin patch provided moderate pain relief compared to a low-concentration (0.04%) control patch, with effects lasting 8-12 weeks. For post-herpetic neuralgia: NNT for at least 30% pain reduction at 8-12 weeks was approximately 8.8. For HIV neuropathy: NNT was approximately 5.8. More participants experienced at least 30% pain reduction with the high-concentration patch than the control. Local adverse effects (application site pain, erythema) were common and expected but generally manageable. No serious systemic adverse effects were attributed to the treatment.
Limitations: The 'placebo' control patch (0.04% capsaicin) is not a true placebo as it produces some burning sensation, which may have therapeutic effect -- meaning the true NNT versus inert placebo may be better than reported. Individual study quality was moderate. Long-term safety of repeated applications (every 3 months for years) is not extensively studied. The 8% patch requires healthcare professional application due to the high concentration and need for anesthetic pre-treatment.
[10]
TRPV1 receptor discovery and Nobel Prize (capsaicin as the key research tool)
David Julius and colleagues at the University of California, San Francisco, used capsaicin as the molecular probe to clone and characterize the TRPV1 (VR1) receptor in 1997, fundamentally advancing understanding of pain sensation and temperature detection.
Findings: Julius's laboratory used capsaicin's highly specific ability to activate pain-sensing neurons as a tool to identify and clone the receptor responsible: TRPV1 (transient receptor potential vanilloid 1), a non-selective cation channel activated by capsaicin, noxious heat (>43 degrees C), protons (acid pH), and various endogenous lipid ligands (endovanilloids). The discovery revealed that the burning sensation caused by capsaicin and the sensation of heat share a common molecular receptor, explaining why capsaicin feels 'hot.' This work, along with Ardem Patapoutian's discovery of mechanosensory ion channels, earned the 2021 Nobel Prize in Physiology or Medicine. The TRPV1 receptor is now a major pharmaceutical target for novel analgesic drug development. Capsaicin's role as the key tool in this discovery makes it one of the most pharmacologically significant natural products in modern biomedical research.
Limitations: Basic science/molecular biology; the Nobel Prize recognized the fundamental receptor discovery rather than clinical applications of capsaicin per se. Translation of TRPV1 research into novel analgesics beyond topical capsaicin itself has been challenging due to the role of TRPV1 in thermoregulation (systemic TRPV1 antagonists cause hyperthermia).
[17]
Topical capsaicin for osteoarthritis (Deal et al. 1991, landmark RCT)
Multicenter, double-blind, randomized, placebo-controlled trial of topical capsaicin cream (0.025%) in patients with painful osteoarthritis of the hands or knees.
Findings: 113 patients with OA applied either capsaicin 0.025% cream or vehicle cream four times daily for 4 weeks. Capsaicin-treated patients had significantly greater reduction in pain by physician global assessment (P = 0.02) and patient global assessment (P = 0.04) compared to vehicle-treated controls. Pain reduction on visual analog scale was significantly greater in the capsaicin group. 80% of capsaicin-treated patients experienced local burning at the application site, which diminished with continued use. The study established topical capsaicin as an evidence-based option for OA pain management.
Limitations: Relatively short study duration (4 weeks). The obvious burning sensation of capsaicin may have compromised blinding. Small sample size. The 0.025% concentration is lower than the 0.075% also available OTC. Long-term efficacy and safety not assessed.
[11]
Topical capsaicin for psoriasis (Bernstein et al. 1986, pioneering study)
Double-blind, vehicle-controlled trial of topical capsaicin (0.025%) in patients with moderate to severe psoriasis, investigating the role of substance P in psoriatic inflammation.
Findings: Patients applied capsaicin cream to psoriatic plaques on one side of the body and vehicle cream to matched plaques on the contralateral side for 6 weeks. Capsaicin-treated lesions showed significantly greater improvement in scaling (P < 0.02), erythema (P < 0.03), and pruritus (P < 0.002) compared to vehicle-treated lesions. The improvement correlated with expected substance P depletion timeline. This was the first demonstration that neurogenic inflammation (substance P-mediated) contributes to psoriatic plaque pathology and that capsaicin-induced substance P depletion could provide therapeutic benefit.
Limitations: Small sample size. Short treatment period. Intra-patient design limits generalizability. Burning at application site was reported by most patients and may have influenced blinding. Capsaicin does not address the underlying autoimmune pathology of psoriasis.
[12]
Capsaicin and thermogenesis/energy expenditure meta-analysis
Meta-analysis of clinical studies investigating the effect of capsaicin and capsinoid consumption on energy expenditure and fat oxidation in humans.
Findings: Analysis of available clinical trials demonstrated that capsaicin/capsinoid consumption significantly increased energy expenditure (mean increase approximately 50 kcal/day at typical dietary doses). Increased fat oxidation was also observed. The thermogenic effect was mediated by TRPV1 activation and sympathetic nervous system stimulation. Higher doses produced greater thermogenic responses. The effect was more pronounced in subjects unaccustomed to regular spicy food consumption (suggesting desensitization with chronic use). The magnitude of the energy expenditure increase, while statistically significant, was judged to be too small for clinically meaningful weight loss as a standalone intervention.
Limitations: Heterogeneous study designs, doses, and populations. Many studies were acute single-dose assessments rather than chronic supplementation trials. The thermic effect may diminish with regular consumption. Clinical weight loss endpoints were not assessed in most included studies. The practical significance of an extra 50 kcal/day expenditure for weight management is debatable.
[16]
Intranasal capsaicin for cluster headache
Clinical investigation of intranasal capsaicin application for prophylaxis and treatment of cluster headache, one of the most severe primary headache disorders.
Findings: Fusco et al. (1994) applied capsaicin intranasally (as a cream preparation) to the ipsilateral nostril of cluster headache patients daily for 7 days. Significant reduction in headache attack frequency was observed compared to baseline, with effects persisting for the duration of the treatment period. The mechanism involves desensitization of trigeminal C-fibers and depletion of CGRP and substance P from trigeminal nerve terminals in the nasal mucosa, which are implicated in the trigeminovascular activation underlying cluster headache. The treatment was tolerable though uncomfortable during the initial applications.
Limitations: Small study populations. Open-label or partially blinded designs in some studies. The nasal burning sensation makes true blinding very difficult. The optimal dosing regimen, frequency, and duration of treatment are not fully established. This remains an investigational approach not yet incorporated into standard cluster headache treatment guidelines.
Capsaicin gastroprotective effects (countering the 'ulcer' myth)
Research investigating whether capsaicin ingestion protects against or promotes gastric mucosal injury, addressing the widespread misconception that spicy foods cause stomach ulcers.
Findings: Contrary to popular belief, multiple lines of evidence indicate that capsaicin at moderate dietary doses is gastroprotective rather than gastro-ulcerogenic. Capsaicin stimulates gastric mucus secretion, increases mucosal blood flow (via CGRP-mediated vasodilation of submucosal vessels), enhances bicarbonate secretion, and at higher doses actually inhibits acid secretion. Epidemiological studies have not found elevated rates of peptic ulcer disease in populations with high chili consumption (e.g., India, Thailand, Mexico). Animal studies demonstrate that capsaicin pre-treatment protects against ethanol-induced and NSAID-induced gastric mucosal injury (a phenomenon termed 'capsaicin-sensitive afferent gastroprotection'). However, capsaicin CAN exacerbate symptoms in patients with pre-existing gastric inflammation, GERD, or active peptic ulcer disease -- the gastroprotective effect operates on healthy mucosa but may not overcome established pathology.
Limitations: Much of the evidence is from animal models. Epidemiological data is observational and confounded by dietary and genetic factors. The dose-response relationship is complex: while moderate capsaicin is protective, very high chronic intake in animal models can produce mucosal damage. Individual sensitivity varies enormously.
Capsaicin and substance P depletion mechanism in detail
Detailed mechanistic studies on how capsaicin achieves analgesic effects through TRPV1 receptor activation, nociceptor desensitization, and substance P depletion from sensory nerve terminals.
Findings: The mechanism of capsaicin analgesia proceeds through a series of well-characterized steps: (1) Capsaicin binds to the vanilloid binding pocket of the TRPV1 receptor on unmyelinated C-fiber nociceptive neurons; (2) TRPV1 channel opening allows calcium influx, triggering action potentials (initial burning/pain) and vesicular release of neuropeptides (substance P, CGRP, neurokinin A) from peripheral nerve terminals; (3) Sustained or repeated TRPV1 activation causes channel desensitization (conformational change reducing calcium permeability), receptor internalization, and downregulation of TRPV1 expression; (4) Depletion of substance P from nerve terminal vesicles occurs because capsaicin-induced release exceeds the rate of substance P re-synthesis and axonal transport; (5) At high concentrations (8% patch), prolonged calcium influx causes osmotic swelling and reversible 'defunctionalization' of sensory nerve terminals, including retraction of epidermal nerve fibers. This defunctionalization is reversible over 3-6 months as nerve fibers regenerate. The 3-5 day lag between initial capsaicin application and onset of significant analgesia corresponds to the time required for meaningful substance P depletion.
Limitations: Much of the detailed mechanistic work is from animal models and cell culture. The degree and rate of substance P depletion in humans at various capsaicin concentrations is inferred rather than directly measured in vivo. Individual variation in TRPV1 receptor density and sensitivity affects the clinical response.
Preparations & Dosage
powder (internal use)
Strength: Whole dried fruit powder, 30,000-90,000 SHU. Standardized products may specify total capsaicinoid content (typically 0.25-0.5%).
Use finely ground dried cayenne pepper powder (30,000-90,000 SHU for standard medicinal cayenne). Can be taken in capsules, stirred into warm water or juice, added to food, or mixed into honey. Start with a very low dose (1/16 to 1/8 teaspoon) and increase gradually over days to weeks as tolerance develops. The Scoville Heat Unit (SHU) rating indicates pungency: 30,000-50,000 SHU is standard cayenne, 50,000-100,000 SHU is 'hot' cayenne, and above 100,000 SHU is 'extra hot.' For reference: bell pepper = 0 SHU, jalapeno = 2,500-8,000 SHU, standard cayenne = 30,000-50,000 SHU, habanero = 100,000-350,000 SHU. The Scoville scale was developed by pharmacist Wilbur Scoville in 1912 using a taste-panel dilution method (Scoville Organoleptic Test); modern measurement uses HPLC to quantify capsaicinoids directly and converts to SHU equivalents (1 mg/kg capsaicin = approximately 15 SHU).
30-120 mg dried powder per dose (approximately 1/16 to 1/4 teaspoon), taken with meals. Commission E: single dose 20-120 mg powder. Typical daily dose: 0.5-1 g (approximately 1/4 to 1/2 teaspoon) divided into 2-3 doses.
1-3 times daily with meals (food in the stomach reduces GI irritation)
May be used long-term as a daily circulatory tonic. Short-term acute use (1-7 days) for colds and fevers.
Not generally recommended for young children in medicinal doses. Adolescents: start with minimal doses under practitioner guidance.
Taking cayenne powder with meals is important to reduce the risk of gastric irritation. Encapsulating the powder in gelatin or vegetarian capsules bypasses the oral burning sensation but also eliminates the sialagogue and reflex digestive stimulation effects. Many herbalists prefer taking cayenne in warm water rather than capsules, arguing that the oral and gastric sensory stimulation is itself therapeutic (triggering the complete digestive reflex arc). Starting with very low doses and building up gradually ('cayenne tolerance training') is essential for patient compliance. Taking cayenne on an empty stomach can cause intense burning and nausea in unaccustomed individuals.
Tincture
Strength: 1:10 in 90% ethanol (dried fruit) or 1:2 in 95% ethanol (fresh fruit). BHP: 1:10 in 60% ethanol.
Prepare from dried cayenne fruit: 1:10 ratio in 90% ethanol (high alcohol concentration needed to dissolve capsaicinoids, which are sparingly soluble in water). Macerate for 14-28 days, shaking daily. Press and filter. Alternatively, a fresh-plant tincture can be prepared at 1:2 in 95% ethanol from fresh ripe cayenne peppers. The tincture should be deep red-orange in color. British Herbal Pharmacopoeia (BHP) specifies a 1:10 tincture in 60% ethanol.
0.25-1 mL (5-20 drops) three times daily, diluted in water or juice. BHP dosage: 0.3-1 mL of 1:10 tincture in 60% ethanol, three times daily. Start with 5 drops and increase as tolerated.
1-3 times daily
May be used long-term as a circulatory tonic. Particularly useful in acute situations (colds, chills) where rapid onset is desired.
Not recommended for children due to pungency and alcohol content.
Cayenne tincture is the preferred preparation for many clinical herbalists because it is easy to dose precisely (by drops), can be added to other herbal tincture formulas as a 'driver/catalyst,' and has rapid onset of action. The high alcohol content is necessary for adequate capsaicinoid extraction. Adding 5-10 drops of cayenne tincture to a larger tincture formula is a common practice to enhance circulatory delivery and bioavailability of other herbs -- the classic 'catalyst' application from the Thomsonian tradition. The tincture is extremely pungent and should always be diluted in water before ingestion.
Capsule / Powder
Strength: 400-500 mg cayenne powder per capsule (30,000-90,000 SHU)
Fill vegetarian or enteric-coated capsules with finely ground cayenne pepper powder (30,000-90,000 SHU). Enteric-coated capsules are available and bypass the oral and gastric burning sensation, releasing the cayenne in the small intestine. Standard capsule sizes: 400-500 mg per capsule.
1-3 capsules (400-500 mg each) 1-3 times daily with meals. Total daily dose: 400-1500 mg cayenne powder per day.
1-3 times daily with meals
May be used long-term for circulatory support
Not generally recommended for children.
Capsules are the most convenient form for patients who cannot tolerate the intense burning of cayenne powder or tincture. However, bypassing the oral mucosa eliminates the sialagogue reflex and may reduce the reflexive stimulation of digestive secretions that contributes to cayenne's carminative and digestive effects. Some herbalists consider capsules therapeutically inferior to direct oral forms for this reason. Enteric-coated capsules are useful for patients who experience gastric irritation with standard capsules. Taking capsules with food is recommended to reduce GI discomfort.
topical cream (OTC analgesic)
Strength: OTC: 0.025%, 0.05%, or 0.075% capsaicin. Prescription: 8% capsaicin patch (Qutenza, applied by healthcare professional).
Apply a thin layer of capsaicin cream (0.025-0.075%) to the affected area 3-4 times daily. Wash hands thoroughly after application (or use gloves). The initial applications will cause a burning sensation that typically diminishes over 3-7 days of consistent use as substance P is depleted. Do NOT apply to broken skin, open wounds, mucous membranes, or near the eyes. Do not bandage tightly over application site. Do not apply heat (heating pad, hot water bottle) to the area after application, as this will intensify burning.
Apply thin layer to affected area 3-4 times daily. Commission E: semi-solid preparations with 0.02-0.05% capsaicinoids. OTC formulations typically 0.025%, 0.05%, or 0.075% capsaicin.
3-4 times daily, consistently, for at least 2-4 weeks to achieve optimal analgesic effect
Can be used long-term. Analgesic benefit builds over 1-4 weeks and is maintained with continued regular application. If application is discontinued, substance P reaccumulates and pain may return over 1-3 weeks.
Not recommended for children under 2 years. Children 2-18: use under medical supervision only.
Topical capsaicin preparations are among the most evidence-based and widely used phytotherapy-derived OTC analgesics. The key to efficacy is consistent, regular application: sporadic use produces the initial burning without achieving the analgesic benefit (substance P depletion requires several days of consistent TRPV1 activation). Patient education is critical -- many patients discontinue prematurely due to the initial burning phase before analgesia is achieved. The burning diminishes markedly after 3-7 days of regular use. The 8% capsaicin patch (Qutenza) is a prescription product applied in a medical setting with prior application of topical anesthetic (lidocaine 4%); a single 30-60 minute application provides 8-12 weeks of pain relief, representing a fundamentally different dosing paradigm than the OTC creams.
capsicum plaster (topical patch)
Strength: Standardized to deliver 10-40 micrograms capsaicinoids per square centimeter (Commission E specification). Commercial products vary by manufacturer.
Apply the capsicum plaster directly to the skin over the painful area. Ensure the skin is clean, dry, and intact (no broken skin, rashes, or wounds). Press firmly to ensure adhesion. Leave in place for the manufacturer-specified duration (typically 12-24 hours). Do not apply to sensitive or thin-skinned areas (face, groin, axillae). Remove if irritation becomes intolerable.
Apply one plaster at a time to the affected area. Commission E: capsicum-containing plasters with 10-40 mcg capsaicinoids per square centimeter. Replace every 24 hours or as directed. Do not use on the same site continuously for more than 3 days without a rest period.
Change every 12-24 hours. Limit continuous use on one site to 2-3 days.
Short-term use for acute muscle pain and spasm: up to 3 days per treatment course. May be reapplied after a rest period.
Not recommended for children under 12.
Capsicum plasters (medicated adhesive patches) have been in continuous pharmaceutical production since the late 19th century and remain among the most widely used topical analgesic products in Europe, particularly Germany (ABC Warme-Pflaster is the best-known brand). The Commission E monograph specifically addresses capsicum plasters for painful muscle spasm in the shoulder, arm, and spine area. The EMA community herbal monograph (2012) recognizes well-established use of capsicum plasters for muscle pain. The plaster format provides sustained, controlled-release delivery of capsaicinoids to the skin, producing counterirritant warmth and analgesia without the messiness of creams. Capsicum plasters are distinct from the 8% capsaicin prescription patch (Qutenza), which delivers a much higher capsaicin concentration for neuropathic pain.
infusion (cayenne tea)
Strength: 0.5-1 g dried cayenne powder per 250 mL water
Add 1/4 to 1/2 teaspoon (0.5-1 g) cayenne powder to a cup (250 mL) of freshly boiled water. Stir well. Allow to steep for 10 minutes. Optionally add honey, lemon juice, and/or fresh ginger to improve palatability. The addition of honey is particularly traditional and also helps coat the throat. Drink while warm. For a milder preparation, start with just a pinch (1/16 teaspoon) and increase gradually.
1 cup, 1-3 times daily. Use lower strength (1/4 teaspoon or less) initially.
1-3 times daily for acute conditions (colds, fevers). 1 time daily as a general circulatory tonic.
Acute use: 1-7 days. As a tonic: may be used daily long-term.
Not recommended for young children. Adolescents: very dilute preparations under adult supervision.
Cayenne tea is the classic Thomsonian preparation and remains the form preferred by many herbalists for acute conditions (colds, flu, chills, poor circulation). The hot liquid enhances the diaphoretic and circulatory-stimulating effects. Traditional combinations include cayenne with elderflower, yarrow, and peppermint for acute febrile conditions (the classic 'sweat tea' formula). Samuel Thomson's composition powder (a blend of bayberry bark, ginger root, cayenne, cloves, and white pine bark) was prepared as an infusion and remains a popular formula in Thomsonian-tradition herbalism.
liniment/oil (topical)
Strength: Approximately 1:10 to 1:5 cayenne to carrier oil or alcohol
Prepare a cayenne-infused oil by combining 1-2 tablespoons cayenne powder with 1 cup (240 mL) of a carrier oil (olive oil, sesame oil, or coconut oil). Warm gently in a double boiler at low heat (not exceeding 65 degrees C / 150 degrees F) for 2-4 hours, stirring occasionally. Strain through cheesecloth. Store in a dark glass bottle. For a stronger preparation (liniment), macerate cayenne powder in rubbing alcohol or vodka (1:5 ratio) for 2-4 weeks, then strain. Apply to affected areas as needed. Avoid mucous membranes and broken skin.
Apply a small amount to the affected area 2-3 times daily. Test on a small skin area first to assess tolerance.
2-3 times daily as needed
As needed for acute pain; several weeks for chronic conditions
Not recommended for children.
Cayenne-infused oil and liniment are traditional preparations used in folk medicine across many cultures (Caribbean pepper-rum liniment, Ayurvedic capsicum taila, Chinese die da jiu-type applications). These preparations are simple to make at home and provide effective topical counterirritant analgesia. The oil-based preparation has the advantage of longer skin contact time compared to alcohol-based liniments. Some formulations add other warming herbs (ginger, mustard, wintergreen) for synergistic action. Always label clearly and keep away from children.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Although rare, allergic reactions to Capsicum have been documented, including contact dermatitis, urticaria, and, extremely rarely, anaphylaxis. Individuals with confirmed Capsicum allergy should avoid all capsicum-containing products. Cross-reactivity with other Solanaceae (tomato, potato, eggplant) is possible but uncommon.
Capsaicin applied to broken, ulcerated, or significantly inflamed skin causes severe burning pain and may delay wound healing. All topical capsaicin product labeling specifies application to intact skin only. Capsicum preparations must not be applied near the eyes or on mucous membranes (nasal, genital, rectal). The Commission E and EMA monographs specify application to intact skin only.
While moderate dietary capsaicin is gastroprotective on healthy mucosa, capsaicin can exacerbate symptoms in patients with active peptic ulcer disease, erosive gastritis, or severe gastroesophageal reflux disease (GERD). Internal medicinal doses should be avoided during active ulceration or acute gastric inflammation. Once the acute condition has resolved, cautious reintroduction at low doses may be appropriate.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Warfarin and other coumarin anticoagulants (Anticoagulants) | moderate | Capsaicin may increase the bioavailability and reduce the hepatic metabolism of warfarin, potentially increasing INR and bleeding risk. In vitro, capsaicin inhibits CYP1A2 and CYP2E1 enzymes, which contribute to warfarin metabolism. There is also a theoretical pharmacodynamic interaction: capsaicin has been shown to inhibit platelet aggregation in vitro, which could potentiate the anticoagulant effect. |
| ACE inhibitors (captopril, enalapril, lisinopril, etc.) (Antihypertensives (ACE inhibitors)) | minor | Capsaicin may exacerbate ACE inhibitor-induced cough. The ACE inhibitor cough is mediated by accumulation of bradykinin and substance P in the respiratory tract. Capsaicin, as a TRPV1 agonist, increases cough reflex sensitivity and substance P release from pulmonary C-fibers, potentially amplifying the cough side effect. |
| Theophylline (Bronchodilators (methylxanthines)) | theoretical | Capsaicin has been reported to increase the rate and extent of theophylline absorption from the GI tract, potentially increasing serum theophylline levels. The mechanism may involve capsaicin-mediated enhancement of gastrointestinal blood flow and/or mucosal permeability. |
| Antihypertensive medications (general) (Antihypertensives) | minor | Capsaicin-mediated CGRP release causes vasodilation that may produce additive hypotensive effects when combined with antihypertensive medications. The effect is generally mild at dietary or standard supplemental doses. |
| Aspirin and NSAIDs (Non-steroidal anti-inflammatory drugs) | minor | Capsaicin inhibits platelet aggregation in vitro, which could theoretically enhance the antiplatelet effect of aspirin and the gastrointestinal bleeding risk of NSAIDs. Paradoxically, capsaicin's gastroprotective effects (increased mucosal blood flow and mucus secretion) might actually help protect against NSAID-induced gastric injury. |
| MAO inhibitors (phenelzine, tranylcypromine, selegiline) (Antidepressants (MAOIs)) | theoretical | Capsaicin promotes catecholamine release from adrenal medulla and sympathetic nerve terminals. MAO inhibitors prevent the degradation of catecholamines (norepinephrine, epinephrine, dopamine). Theoretically, the combination could result in an exaggerated catecholamine response with hypertension or tachycardia. |
Pregnancy & Lactation
Pregnancy
likely safe
Lactation
likely safe
Cayenne pepper consumed in normal dietary (culinary) amounts is generally considered safe during pregnancy and lactation, and populations worldwide consume chili-spiced foods throughout pregnancy without documented adverse effects. The AHPA classifies capsicum as Class 1 (safe when used appropriately). However, medicinal/therapeutic doses (concentrated supplements, high-dose capsules, or tinctures) should be used with caution during pregnancy: capsaicin can cross the placenta, and high doses have produced embryotoxicity in some animal studies (at doses far exceeding normal dietary intake). There is a theoretical concern that capsaicin may promote uterine contractions at very high doses, though this has not been demonstrated in humans at culinary or standard medicinal doses. During lactation, capsaicin is excreted in breast milk in small amounts; some infants may show irritability or refuse nursing if the mother consumes very large amounts of spicy food, but this is uncommon and self-limiting. The Commission E and WHO monographs do not specifically contraindicate dietary capsicum in pregnancy.
Adverse Effects
References
Monograph Sources
- [1] Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS (eds.). The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines -- Capsicum (Capsici fructus). American Botanical Council, Austin, TX / Integrative Medicine Communications, Boston (1998)
- [2] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1 -- Fructus Capsici. World Health Organization, Geneva (1999)
- [3] European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community Herbal Monograph on Capsicum annuum L. var. minimum (Miller) Heiser and small fruited varieties of Capsicum frutescens L., fructus (Capsici fructus acer). EMA/HMPC/253630/2007 (2012)
- [4] British Herbal Medicine Association. British Herbal Pharmacopoeia -- Capsicum. BHMA, Bournemouth (1983)
- [5] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003)
- [6] Bone K, Mills S. Principles and Practice of Phytotherapy: Modern Herbal Medicine (2nd edition). Churchill Livingstone/Elsevier, Edinburgh (2013)
- [7] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook (2nd edition) -- Capsicum annuum. CRC Press/Taylor & Francis, Boca Raton, FL (2013)
- [8] Thomson S. New Guide to Health; or, Botanic Family Physician. J.Q. Adams, Boston, MA. Second edition, 1825. (1822)
Clinical Studies
- [9] Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ (2004) ; 328 : 991 . DOI: 10.1136/bmj.38042.506748.EE . PMID: 15033881
- [10] Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev (2017) ; 1 : CD007393 . DOI: 10.1002/14651858.CD007393.pub4 . PMID: 28085183
- [11] Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, Albert D, Renold F. Treatment of arthritis with topical capsaicin: a double-blind trial. Clin Ther (1991) ; 13 : 383-395 . PMID: 1954640
- [12] Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH Jr. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol (1986) ; 15 : 504-507 . DOI: 10.1016/S0190-9622(86)70201-6 . PMID: 3760276
- [13] The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: a multicenter, double-blind, vehicle-controlled study. Arch Intern Med (1991) ; 151 : 2225-2229 . DOI: 10.1001/archinte.1991.00400110065013 . PMID: 1953227
- [14] Fusco BM, Marabini S, Maggi CA, Fiore G, Geppetti P. Preventive effect of repeated nasal applications of capsaicin in cluster headache. Pain (1994) ; 59 : 321-325 . DOI: 10.1016/0304-3959(94)90017-5 . PMID: 7708406
- [15] Marks DR, Rapoport A, Padla D, Pirio R, Lush F, Hopcia P, Golden S. A double-blind placebo-controlled trial of intranasal capsaicin for cluster headache. Cephalalgia (1993) ; 13 : 114-116 . DOI: 10.1046/j.1468-2982.1993.1302114.x . PMID: 8495453
- [16] Whiting S, Derber E, Thalheimer JC, Whitworth BN, Papadopoulos S, Boylan D. Could capsaicinoids help to support weight management? A systematic review and meta-analysis of energy intake data. Appetite (2014) ; 73 : 183-188 . DOI: 10.1016/j.appet.2013.11.005 . PMID: 24246368
Traditional Texts
- [17] Julius D. TRP channels and pain (Nobel Prize lecture). Nobel Prize in Physiology or Medicine 2021, awarded jointly to David Julius and Ardem Patapoutian for their discoveries of receptors for temperature and touch (2021)
Pharmacopeias & Reviews
- [18] European Directorate for the Quality of Medicines (EDQM). European Pharmacopoeia, 10th Edition -- Capsicum (Capsici fructus acer). Council of Europe, Strasbourg (2021)
- [19] United States Pharmacopeial Convention. United States Pharmacopeia / National Formulary (USP-NF) -- Capsaicin; Capsicum; Capsicum Oleoresin. United States Pharmacopeial Convention, Rockville, MD (2022)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.